ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Short Interest Up 22.6% in December

Posted by Maddie Sorensen on Dec 31st, 2024

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 10,300 shares, an increase of 22.6% from the November 30th total of 8,400 shares. Based on an average daily volume of 12,700 shares, the short-interest ratio is presently 0.8 days.

Institutional Investors Weigh In On ProShares UltraShort Nasdaq Biotechnology

A hedge fund recently bought a new stake in ProShares UltraShort Nasdaq Biotechnology stock. Jane Street Group LLC bought a new stake in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 10,520 shares of the company’s stock, valued at approximately $158,000. Jane Street Group LLC owned about 4.78% of ProShares UltraShort Nasdaq Biotechnology as of its most recent filing with the Securities & Exchange Commission.

ProShares UltraShort Nasdaq Biotechnology Price Performance

Shares of NASDAQ BIS traded down $0.08 during midday trading on Tuesday, hitting $18.34. 3,255 shares of the company traded hands, compared to its average volume of 14,055. ProShares UltraShort Nasdaq Biotechnology has a 12-month low of $14.05 and a 12-month high of $21.10. The stock has a 50-day moving average price of $16.38 and a 200 day moving average price of $15.74.

ProShares UltraShort Nasdaq Biotechnology Increases Dividend

The company also recently announced a dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Monday, December 23rd will be given a $0.2064 dividend. The ex-dividend date of this dividend is Monday, December 23rd. This is a positive change from ProShares UltraShort Nasdaq Biotechnology’s previous dividend of $0.15.

ProShares UltraShort Nasdaq Biotechnology Company Profile

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.